{"id":"W4410983248","doi":"10.1016/j.eururo.2025.05.017","title":"Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Long-term Outcomes from the JAVELIN Bladder 100 Trial in Patients with Nonvisceral or Lymph Node–only Disease","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Merck KGaA; Merck","keywords":"Medicine; Metastatic Urothelial Carcinoma; Avelumab; Hazard ratio; Internal medicine; Oncology; Lymph node; Clinical endpoint; Regimen; Carcinoma; Bladder cancer; Confidence interval; Randomized controlled trial; Urothelial carcinoma; Cancer; Pembrolizumab; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001667125,0.0004092401,0.0005995771,0.0001107902,0.0001598164,0.0000284463,0.0003336796,0.00007317485,0.0002550572],"category_scores_gemma":[0.0003402786,0.0002324927,0.0001815041,0.000191605,0.0001908079,0.0000718733,0.0001243018,0.0002328905,0.00006136271],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001362684,"about_ca_system_score_gemma":0.0004683092,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001120431,"about_ca_topic_score_gemma":0.0002782848,"domain_scores_codex":[0.9976966,0.0002460703,0.0005405891,0.0007167345,0.0002353106,0.0005647233],"domain_scores_gemma":[0.9984552,0.0003906552,0.0001490549,0.0007053301,0.0001323692,0.0001673863],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2203743,0.0009030858,0.7700164,0.00003216096,0.0002478652,0.0002299976,0.0001633154,0.00004075859,0.000002692773,0.00003127136,0.0005454884,0.007412645],"study_design_scores_gemma":[0.1844148,0.001604594,0.811402,0.00005865762,0.000419934,0.000002671327,0.000009247477,0.00005227501,0.000005775781,0.00003570894,0.001801428,0.0001929063],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9873146,0.0002324981,0.001138159,0.005640577,0.0009173618,0.002974616,0.0005356839,0.00006896104,0.001177587],"genre_scores_gemma":[0.9865164,0.00002665362,0.0002154045,0.008780253,0.0004153544,0.000182834,0.0003047035,0.00009115291,0.003467223],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04138554,"threshold_uncertainty_score":0.9480776,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01922691504164975,"score_gpt":0.2750866555957063,"score_spread":0.2558597405540566,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}